Bio-Works Technologies AB (publ) (FRA:1BD)

Market Cap	21.07M
Revenue (ttm)	4.20M
Net Income (ttm)	-2.69M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	101
Open	0.2370
Previous Close	0.2440
Day's Range	0.2370 - 0.2370
52-Week Range	0.0468 - 0.3190
Beta	n/a
RSI	62.23
Earnings Date	Feb 19, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2006
• Employees: 30
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1BD

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.

Financial numbers in SEK